Figure 1From: Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritisTime course of median percentage change in (A) haematological and (B) inflammatory markers. Patients received tocilizumab + MTX. TIBC, total iron-binding capacity. MTX, methotrexate.Back to article page